| Literature DB >> 25912046 |
Daniel J Jackson1, Karlheinz Mann2, Vreni Häussermann3, Markus B Schilhabel4, Carsten Lüter5, Erika Griesshaber6, Wolfgang Schmahl6, Gert Wörheide7.
Abstract
Brachiopods are a lineage of invertebrates well known for the breadth and depth of their fossil record. Although the quality of this fossil record attracts the attention of paleontologists, geochemists, and paleoclimatologists, modern day brachiopods are also of interest to evolutionary biologists due to their potential to address a variety of questions ranging from developmental biology to biomineralization. The brachiopod shell is a composite material primarily composed of either calcite or calcium phosphate in close association with proteins and polysaccharides which give these composite structures their material properties. The information content of these biomolecules, sequestered within the shell during its construction, has the potential to inform hypotheses focused on describing how brachiopod shell formation evolved. Here, using high throughput proteomic approaches and next generation sequencing, we have surveyed and characterized the first shell-proteome and shell-forming transcriptome of any brachiopod, the South American Magellania venosa (Rhynchonelliformea: Terebratulida). We find that the seven most abundant proteins present in the shell are unique to M. venosa, but that these proteins display biochemical features found in other metazoan biomineralization proteins. We can also detect some M. venosa proteins that display significant sequence similarity to other metazoan biomineralization proteins, suggesting that some elements of the brachiopod shell-forming proteome are deeply evolutionarily conserved. We also employed a variety of preparation methods to isolate shell proteins and find that in comparison to the shells of other spiralian invertebrates (such as mollusks) the shell ultrastructure of M. venosa may explain the effects these preparation strategies have on our results.Entities:
Keywords: Brachiopoda; Magellania; biomineralization; evolution; proteome; transcriptome
Mesh:
Substances:
Year: 2015 PMID: 25912046 PMCID: PMC4453069 DOI: 10.1093/gbe/evv074
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
FSimplified phylogeny of the Brachiopoda based on Sperling et al. (2011).
FPAGE analysis of M. venosa shell matrices. Lanes D2h (dorsal, 2 h of sodium hypochlorite treatment) and V2h (ventral, 2 h of sodium hypochlorite treatment) show matrix extracted after a 2-h treatment of entire shells with sodium hypochlorite. Lanes D24h and V24h show matrix extracted after an additional treatment of powdered shells for 24 h. The molecular weight of marker proteins is shown in kDa on the left.
Major Proteins of the Magellania venosa Shell Matrix
| Contig ID | Protein ID | BLAST Hits | Interpro Domains; Transmembrane Helices; Disordered Domains; Phosphorylation | % of Total Identified Dorsal Proteome 2/24 h | % of Total Identified Ventral Proteome 2/24 h | pI | SS | Anomalous Amino Acid Contents |
|---|---|---|---|---|---|---|---|---|
| 12373 | R20074237 | Uncharacterized | 2 TMH; DI | 13.8/8.4 | 11.6/8.0 | 4.34 | Y | Asp 12.1% |
| 10941 | F20065642 | Uncharacterized | — | 7.8/13.4 | 7.9/13.6 | 8.88 | N | — |
| 13662 | R30081972 | Uncharacterized | — | 9.6/8.3 | 5.0/8.3 | 9.34 | N | — |
| 8496 | F20050972 | Uncharacterized | — | 7.8/14.4 | 6.4/13.2 | 5.7 | Y | — |
| 16167 | R20097001 | Uncharacterized | TIMP like OB fold | 6.8/9.8 | 6.1/10.4 | 9.96 | N | — |
| 9860 | F30059157 | Uncharacterized | Phosphorylation: S174 (90%) | 4.8/0.6 | 4.4/0.6 | 9.71 | N | Gly 29.3% |
| 10182 | R10061090 | Uncharacterized | DI | 3.2/4.5 | 5.0/4.4 | 4.37 | Y | Asp 15.4% |
| 14565 | R20087389 | Similar to mesenchyme-specific cell surface glycoprotein/calcium and integrin-binding family member 2 | WD40/YVTN repeat like; DI | 4.5/5.3 | 3.1/5.2 | 9.19 | N | — |
| 13892 | R30083352 | Uncharacterized | — | 2.9/3.2 | 3.5/3.0 | 11.38 | Y | — |
| 481 | R20002885 | Uncharacterized | — | 2.8/0.1 | 3.0/0.1 | 9.88 | N | Gly 17.3% |
| 10544 | R20063263 | Uncharacterized | Phosphorylation: S73 (4%) | 2.4/2.7 | 2.9/2.5 | 6.64 | N | Ser 10.4% |
| 21084 | R10126502 | Uncharacterized | FAD linked oxidase N term | 2.1/<0.01 | 2.9/0.0 | 10.35 | Y | — |
| 6089 | F10036529 | Similar to complement receptor type 1 | Sushi/SCR/CCP (8×) | 2.4/5.6 | 2.3/5.8 | 6.28 | Y | — |
| 8840 | F20053036 | Uncharacterized | 2 TMH | 2.0/2.2 | 2.6/1.9 | 9.63 | Y | — |
| 25732 | R10154390 | Uncharacterized | — | 1.8/1.4 | 1.2/1.2 | 9.85 | Y | — |
| 17985 | F20107906 | Similar to peroxidasin | Haem peroxidase, TSP1 repeat | 1.3/0.0 | 1.2/0.0 | 9.12 | N | — |
| 17302 | R20103811 | Uncharacterized | 2 TMH | 1.0/0.1 | 1.1/0.1 | 6.01 | N | Ala 11.8% |
| 16240 | R10097438 | Uncharacterized | FAD linked oxidase N term, berberine; 3 TMH | 0.5/0.0 | 1.3/0.0 | 9.64 | N | — |
| 8882 | F20053288 | Uncharacterized | 1 TMH | 0.8/0.6 | 1.0/0.7 | 9.99 | Y | Gly 14.5% |
| 10588 | R10063526 | Uncharacterized | DI; phosphorylation: S272 (1%), S277 (9%), doubly phosphorylated peptide (69%) | 0.6/0.0 | 1.2/0.0 | 4.48 | Y | Gly 19.4%, Ser 22.6% |
| 17072 | R30102432 | Uncharacterized | — | 0.7/0.6 | 0.8/0.5 | 9.14 | Y | — |
| 1404 | R10008422 | Uncharacterized | DI | 0.8/1.1 | 0.6/1.3 | 9.49 | N | Ser 10.6% |
| 3349 | F10020089 | Uncharacterized | DI | 0.6/0.0 | 0.8/0.0 | 4.29 | N | Glu 19.5%, Ser 11.9% |
| 25890 | F30155337 | Uncharacterized | DI | 0.6/0.5 | 0.8/0.4 | 12.18 | N | — |
| 12037 | F10072217 | Similar to collagen α5 (VI), nontriple helical region | — | 0.7/0.2 | 0.7/0.2 | 10.01 | Y | Gly 11.5% |
| 1290 | R30007740 | Uncharacterized | VWA | 0.7/0.0 | 0.4/0.0 | 10.14 | N | — |
| 24592 | R20147551 | Uncharacterized | — | 0.4/0.0 | 0.6/0.0 | 9.6 | N | Lys 11.0% |
| 13443 | F30080655 | Uncharacterized | 1 TMH | 0.5/0.2 | 0.5/0.1 | 9.59 | Y | — |
| 3937 | R10023620 | Similar to CRE-TYR-3 | Tyrosinase | 0.3/0.0 | 0.6/0.0 | 9.06 | N | Cys 9.6%, Gly 10.9% |
| 3968 | F10023803 | Similar to mesenchyme-specific cell surface glycoprotein | WD40/YVTN repeat like/cytochrome cd1 (cyt cd1) nitrite reductase like, haem d1; DI | 0.4/1.5 | 0.4/1.7 | 6.47 | N | — |
| 6648 | R30039888 | Similar to lactadherin | Galactose binding like/coagulation factor 5/8 C | 0.3/0.8 | 0.6/0.7 | 9.41 | N | — |
| 12090 | F10072535 | Uncharacterized | DI | 0.4/1.0 | 0.3/1.2 | 8.85 | N | Gly 10.2% |
| 14281 | F10085681 | Similar to hemagglutinin family protein | DI | 0.5/0.4 | 0.3/0.4 | 5.12 | N | Ser 11.3% |
| 23379 | F20140270 | Uncharacterized | — | 0.5/1.9 | 0.3/1.9 | 10.42 | N | Gly 12.8% |
| 10375 | R10062248 | Uncharacterized | 3 TMH; DI | 0.5/0.7 | 0.3/0.8 | 10.91 | Y | Ala 11.2% |
| 22890 | R30137340 | Uncharacterized | ConA-like lectin | 0.1/0.0 | 0.6/0.0 | 9.72 | Y | — |
| 20588 | R20123527 | Uncharacterized | 1 TMH | 0.3/0.3 | 0.4/0.3 | 9.47 | N | — |
| 26985 | F30161907 | Uncharacterized | — | 0.3/0.0 | 0.3/0.0 | 9 | N | Ser 13.7% |
| 14828 | R20088967 | Similar to complement receptor type 1 | — | 0.3/0.8 | 0.2/0.9 | 6.85 | Y | Gly 10.4% |
| 16143 | F30096855 | Uncharacterized | — | 0.4/0.4 | 0.3/0.4 | 9.02 | Y | — |
| 4638 | R30027828 | Uncharacterized | DOMON, SEA | 0.3/0.3 | 0.1/0.5 | 4.84 | N | — |
| 8473 | R10050836 | Uncharacterized/similar to peroxinectin | Haem peroxidase 3 | 0.1/<0.01 | 0.2/0.0 | 9.25 | N | — |
| 10638 | F10063823 | Uncharacterized | Sushi/SCR/CCP (8×); 1 TMH; DI | 0.2/1.1 | 0.2/1.1 | 9.39 | N | — |
| 14771 | F20088622 | Uncharacterized | 1 TMH; DI | 0.2/0.4 | 0.2/0.4 | 10.07 | N | — |
| 17017 | R20102101 | Similar to noelin-2 | Olfactomedin like | 0.1/0.0 | 0.3/0.0 | 9.14 | N | — |
| 19193 | R30115158 | Uncharacterized | CUB; 1 TMH | 0.3/0.3 | 0.2/0.4 | 8.66 | N | — |
| 19686 | F20118112 | Uncharacterized | — | 0.0/0.0 | 0.3/0.0 | 5.26 | N | — |
| 22374 | F30134241 | Uncharacterized | — | 0.0/0.1 | 0.4/0.1 | 8.91 | N | Cys 8.2%, Gly 18.9% |
| 22496 | F10134971 | Uncharacterized | — | 0.3/0.0 | 0.1/0.0 | 9.3 | N | — |
| 26237 | F30157419 | Uncharacterized | — | 0.2/0.1 | 0.2/0.1 | 7.89 | N | — |
| 1954 | F20011720 | Neutral ceramidase B | Neutral/alkaline nonlysosomal ceramidase | 0.2/0.2 | 0.2/0.2 | 8.26 | Y | — |
| 24553 | R10147316 | Uncharacterized | TSP1 | 0.3/0.1 | 0.2/0.2 | 8 | Y | Cys 10.0%, Gly 11.0% |
| 26581 | F10159481 | Uncharacterized | DI | 0.2/0.1 | 0.2/0.1 | 11.96 | Y | — |
| 1953 | R10011716 | Neutral/alkaline nonlysosomal ceramidase | Neutral/alkaline nonlysosomal ceramidase; 1 TMH | 0.1/0.2 | 0.1/0.2 | 7.77 | N | — |
| 3405 | F30020427 | Similar to cysteine-rich secretory protein LCCL domain-containing 2 | CAP | 0.2/0.0 | 0.1/0.0 | 7.92 | N | — |
| 14004 | R10084022 | Uncharacterized | — | 0.1/0.1 | 0.1/0.1 | 9.27 | N | — |
| 20189 | F20121130 | Uncharacterized | — | 0.1/0.0 | 0.1/0.0 | 9.67 | N | Lys 10.1% |
| 20189 | F30121131 | Uncharacterized | DI | 0.1/0.0 | 0.2/0.0 | 9.69 | N | — |
| 21060 | R20126359 | Similar to MAM domain-containing glycosylphosphatidylinositol anchor protein 1 | ConA like lectin/MAM, peptidase S1 | 0.1/0.2 | 0.1/0.1 | 8.38 | N | — |
| 21061 | R30126366 | Similar to atrial natriuretic peptide-converting enzyme | LDLRA 2, SCRC 2, Peptidase S1/trypsin | 0.1/0.2 | 0.1/0.2 | 8.46 | N | — |
| 14224 | F10085339 | Uncharacterized | EGF; DI | 0.1/0.1 | 0.0/0.1 | 7.04 | Y | — |
| 18776 | R30112656 | Uncharacterized | CUB; 1 TMH | 0.1/0.1 | 0.1/0.1 | 8.02 | Y | — |
| 21109 | F30126651 | Uncharacterized | — | 0.0/0.2 | 0.0/0.2 | 6.69 | N | — |
| 27260 | F20163556 | Similar to SCO-spondin/hemicentin-1 | TSP-1 | 0.0/0.3 | 0.0/0.3 | 8.4 | N | Cys 14.8%, Ser 11.8% |
| 24557 | R30147342 | Uncharacterized | 1 TMH | 0.1/0.8 | <0.010/0.8 | 5.52 | Y | Cys 11.2%, Gly 12.1% |
| 17584 | R20105503 | Uncharacterized | Trypsin inhibitor like Cys-rich | 0.0/0.6 | <0.01/1.1 | 10.03 | Y | Cys 7.6%, Gly 16.0% |
Note.—Major proteins were arbitrarily defined as proteins occurring with an average percentage of ≥0.1 in either D1–3 and V1–3 (2 h) or D4–6 and V4–6 (24 h) or both. Known intracellular proteins or membrane proteins with predominantly intracellular function, some of which showed high percentages in samples treated with hypochlorite for 2 h only, are not included. DI, predicted disordered structure; TMH, predicted transmembrane helices; SS, predicted secretion signal peptide.
aPossibly a fragment of the same protein as peptide R10097438.
bPossibly the same protein as contig 14828 (R20088967), possibly the N-terminal half.
cShares two peptides with R10050836.
dPossibly a fragment of the same protein as peptide R10126502.
ePossibly the same protein as contig 6089 (F10036529)—possibly the C-terminal half.
fShares peptides with F20107906.
FSequence-based comparisons of M. venosa’s shell-forming proteome against other metazoan data sets. BLASTp based similarity comparison of the 66 most abundant M. venosa shell proteins against 765 shell-forming proteomes derived from eight other biocalcifying metazoans. All 66 major M. venosa shell proteins were searched against a concatenated database of shell-forming proteins derived from P. maxima and P. margaritifera (Marie et al. 2012); H. asinina; (Marie et al. 2010); L. gigantea; (Marie et al. 2013); C. gigas (Zhang et al. 2012), S. purpuratus (Mann et al. 2008), and A. millepora (Ramos-Silva et al. 2014) using BLASTp and an e-value cut-off of 10 e-06. Individual lines spanning the ideogram connect proteins that share significant similarity (e values < 10 e-6). Transparent red lines connect proteins with the lowest quartile of similarity (with a threshold of 10 e-6) and green lines with the highest quartile of similarity. The percentage of each shell proteome that shared similarity with the M. venosa proteome is provided.
FSpectrum of the major phospho-peptides of R10063526 and F30059157. (A) The doubly phosphorylated R10063526 peptide containing phosphorylated S272 and S277 of this entry was identified with a posterior error probability (PEP) of 0.0002 and a mass error of 0.7 ppm. The MaxQuant localization probability was 1 for both sites. Expert System advanced annotations (Neuhauser et al. 2012) were omitted to reduce complexity, except for the last two peaks (m/z 1,144.41 and 1,045.44). Peak X was not annotated by the expert system but most probably represents [M+H]-2H3PO4-H2O. Y-ions are shown in red, b-ions are shown in blue, b- or y-ions with a loss of water or ammonia are in orange. Asterisks indicate loss of H3PO4. (B) The singly phosphorylated F30059157 peptide (S174) was identified with a mass error of 0.7 ppm, a PEP of 3.4 e-67, and a phosphosite localization probability of 1. Y-ions are shown in red, b-ions are shown in blue, b- or y-ions with a loss of water or ammonia are in orange. Asterisks indicate loss of H3PO4. Expert System advanced annotations (Neuhauser et al. 2012) are omitted for clarity of presentation.
FEffect of 2- versus 24-h sodium hypochlorite treatment on the abundance of proteins in dorsal and ventral shell valves. The relative abundances of 333 minor proteins (red circles) and 66 major proteins (blue circles) identified in M. venosa shells were compared following 2- versus 24-h treatment with sodium hypochlorite. iBAQ values for each peptide recorded after 24 h of treatment were subtracted from those recorded after 2 h of treatment. Negative values therefore indicate a higher peptide abundance in 24 h treated samples.
FSEM images of punctae in the shell of M. venosa. (a) Punctae in a broken valve of M. venosa (view from inside of shell) with fibrous structure (F) of secondary shell layer clearly visible. (b) Punctae in a broken shell of M. venosa (view from outside of shell) at the interface of the primary (P, right side of image) and fibrous secondary layers (F, left side of image).